GL1X · GenesisL1 explorer

Research workbench

Human cyclophilin a complexed with THR2, LEU5, D-HIV8, LEU10 cyclosporin

Analyse Human cyclophilin a complexed with THR2, LEU5, D-HIV8, LEU10 cyclosporin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1CWO
Type
protein
Length
175 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptidyl-prolyl cis-trans isomerase a; Cyclosporin C
EC
5.2.1.8
UniProt
P62937
Ligands
VAD

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptidyl-prolyl cis-trans isomerase a (EC 5.2.1.8)protein16514% helix, 33% strandP62937
CCyclosporin Cprotein100% helix, 10% strand—

Ligands and binding sites

  • VAD · Deaminohydroxyvaline · ligand · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–C · 508 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 modified, 2 covalent (nonstandard, covalent ligand, methylation).

Compared structures

  • 1CWO · Human cyclophilin a complexed with THR2, LEU5, D-HIV8, LEU10 cyclosporin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.